Informations générales (source: ClinicalTrials.gov)
Onset and Offset of Von Willebrand Factor Multimemirization Defects in Cardiovascular Disease: the Case of the Molecular Sensor of Blood Flow (WiTAVi)
Observational
University Hospital, Lille (Voir sur ClinicalTrials)
août 2012
janvier 2018
29 juin 2024
The WITAVI study was designed to explore the kinetic and associated outcome of Von
Willebrand Factor-multimerizaton defects associated with devices in cardiovascular
diseases.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Lille University Hospital - 59037 - Lille - France | Sophie Susen, MD,PhD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Adult patients > 18 years who need a mechanical circulatory support due to advanced
heart failure or undergoing trans-aortic-valve-replacement to treat aortic stenosis.
- Informed consent of the patient or support person in case of disability at baseline
(patient intubated and ventilated)
- Adult patients > 18 years who need a mechanical circulatory support due to advanced
heart failure or undergoing trans-aortic-valve-replacement to treat aortic stenosis.
- Informed consent of the patient or support person in case of disability at baseline
(patient intubated and ventilated)
- Patient with a known severe bleeding disorder
- Patient refusal or environment
- Minor patients
- Pregnant women